Stay away from concomitant usage of tucatinib with CYP3A substrates, where minimal focus adjustments may bring about really serious or lifestyle-threatening toxicities. If unavoidable, minimize CYP3A substrate dose In accordance with product or service labeling.Lonafarnib may perhaps boost the AUC and peak focus of CYP2C19 substrates. If coadminist